Nicardipine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
Published February 28, 2018 · Recall initiated: December 27, 2017
Summary
FDA records drug Class II recall D-0469-2018, published February 28, 2018 and initiated December 27, 2017. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: Unknown; Lot: All lots remaining within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmedium Services, LLC
- Distributor
- U.S.A. Nationwide
- Lot
- All lots remaining within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00January 1, 2020
- FDAFentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%,December 26, 2018
- FDARocuronium Bromide in all strengths, all doses, and all packaging.February 28, 2018
- FDABaclofen USP (Micronized) for prescription compounding, packaged in a) 25g (NDC 58597-8004-4); b)100g (NDCFebruary 28, 2018
Questions about this recall
Was Nicardipine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging. recalled?
Yes. FDA published recall D-0469-2018 on February 28, 2018. Reported hazard: Lack of sterility assurance.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release